FR2693907B1
(fr)
*
|
1992-07-23 |
1994-09-02 |
Rhone Poulenc Rorer Sa |
Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
WO1995010989A1
(en)
*
|
1993-10-19 |
1995-04-27 |
Scimed Life Systems, Inc. |
Intravascular stent pump
|
US5496360A
(en)
*
|
1994-04-12 |
1996-03-05 |
Ventritex, Inc. |
Implantable cardiac electrode with rate controlled drug delivery
|
ES2183841T3
(es)
*
|
1994-06-13 |
2003-04-01 |
Alza Corp |
Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5718700A
(en)
*
|
1994-09-20 |
1998-02-17 |
Alza Corporation |
Exit means in dosage form
|
US6036669A
(en)
|
1995-01-13 |
2000-03-14 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
US5531734A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Method of altering composition of nutritional product during enteral tube feeding
|
US5533973A
(en)
*
|
1995-01-13 |
1996-07-09 |
Abbott Laboratories |
Alteration of nutritional product during enteral tube feeding
|
US5531682A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Apparatus for adding marker dye to nutritional product during enternal tube feeding
|
US6277092B1
(en)
|
1995-01-13 |
2001-08-21 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
US5531681A
(en)
*
|
1995-01-13 |
1996-07-02 |
Abbott Laboratories |
Apparatus for altering composition of nutritional product during enteral tube feeding
|
FR2731154B1
(fr)
*
|
1995-03-03 |
1997-05-09 |
Roussel Uclaf |
Compositions pharmaceutiques comprenant des derives de dinoreburnamenine
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US6156331A
(en)
*
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
EP1238657B1
(en)
*
|
1996-02-02 |
2004-11-03 |
ALZA Corporation |
Sustained delivery of an active agent using an implantable system
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
CN100388916C
(zh)
*
|
1997-12-22 |
2008-05-21 |
阿尔扎有限公司 |
用于控释药物传递装置的速率控制膜
|
US6080132A
(en)
*
|
1998-02-27 |
2000-06-27 |
Abbott Laboratories |
Apparatus for altering characteristics of a fluid
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AU3885799A
(en)
*
|
1998-05-14 |
1999-11-29 |
Alza Corporation |
Antidepressant therapy
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US6309373B1
(en)
|
1998-08-12 |
2001-10-30 |
Abbott Laboratories |
Apparatus for altering the characteristics of a fluid
|
US6183466B1
(en)
|
1998-08-21 |
2001-02-06 |
Alza Corporation |
Dosage form comprising a capsule
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
EP1112060B1
(en)
*
|
1998-09-09 |
2005-12-07 |
ALZA Corporation |
Dosage form comprising liquid formulation
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US6706282B1
(en)
*
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
GB9824658D0
(en)
*
|
1998-11-11 |
1999-01-06 |
Brown Malcolm D |
A capsule based drug delivery system
|
PT1140012E
(pt)
*
|
1998-12-17 |
2004-05-31 |
Alza Corp |
Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
|
JP4864204B2
(ja)
|
1998-12-18 |
2012-02-01 |
アルザ・コーポレーション |
透明な経皮的ニコチン送達デバイス
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
JP3061616B1
(ja)
*
|
1999-04-09 |
2000-07-10 |
株式会社セラリカ野田 |
低カロリ―調製ロ―ヤルゼリ―
|
DE19923817A1
(de)
*
|
1999-05-18 |
2000-11-23 |
Roland Bodmeier |
Kapsel mit kontrollierter Wirkstofffreisetzung
|
US20040230155A1
(en)
*
|
1999-06-22 |
2004-11-18 |
Erblan Surgical Inc. |
Insufflator and method of use
|
US20060015075A1
(en)
*
|
1999-06-22 |
2006-01-19 |
Erblan Surgical Inc. |
Guarded infusor needle and infusor locking system
|
US6251432B1
(en)
|
1999-07-01 |
2001-06-26 |
Abbott Laboratories |
Sustained release dosage form unit having latex coating and method of making the same
|
EP1239840B1
(en)
*
|
1999-12-09 |
2005-04-06 |
Alza Corporation |
Antiviral medication
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
WO2001056543A1
(en)
|
2000-02-04 |
2001-08-09 |
Alza Corporation |
Osmotically-driven fluid dispenser and coating composition
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
GB0003424D0
(en)
*
|
2000-02-16 |
2000-04-05 |
Bioprogress Tech Int Inc |
A controlled release capsule
|
GB2398499B
(en)
*
|
2000-02-16 |
2004-11-24 |
Bioprogress Technology Ltd |
Two layer capsules
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6468559B1
(en)
*
|
2000-04-28 |
2002-10-22 |
Lipocine, Inc. |
Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
|
US20020161387A1
(en)
*
|
2000-06-22 |
2002-10-31 |
Blanco Ernesto E. |
Safety trocar with progressive cutting tip guards and gas jet tissue deflector
|
US20040230160A1
(en)
*
|
2000-06-22 |
2004-11-18 |
Erblan Surgical Inc. |
Safety trocar including sealing member
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
AU2587002A
(en)
*
|
2000-11-03 |
2002-05-15 |
Biomedicines Inc |
Method for short-term and long-term drug dosimetry
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
DE10100689A1
(de)
*
|
2001-01-09 |
2002-07-18 |
Henkel Kgaa |
Wasch- und reinigungsaktive Substanzen enthaltende Mikrokapseln
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
JP4307995B2
(ja)
*
|
2001-07-12 |
2009-08-05 |
ギブン イメージング リミテッド |
身体の管腔を検査するための装置
|
US7349733B2
(en)
*
|
2001-11-02 |
2008-03-25 |
Ceramatel, Inc. |
Iontophoretic drug delivery systems
|
US20030143197A1
(en)
*
|
2001-11-09 |
2003-07-31 |
Moran S. Mark |
Method for treating diseases with omega interferon
|
US20030232078A1
(en)
*
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
HUP0402451A3
(en)
*
|
2001-12-19 |
2008-04-28 |
Alza Corp |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US7047069B2
(en)
|
2002-02-04 |
2006-05-16 |
Ceramatec, Inc. |
Iontophoretic fluid delivery device
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US20040052848A1
(en)
*
|
2002-05-23 |
2004-03-18 |
Xiu-Xiu Cheng |
Biguanide formulations
|
EP1536767B1
(en)
*
|
2002-06-17 |
2007-08-08 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
BR0312429A
(pt)
*
|
2002-06-26 |
2005-04-19 |
Alza Corp |
Pistão de deformidade mìnima e de volume eficiente para sistemas de distribuição de drogas por osmose
|
AR040301A1
(es)
*
|
2002-06-28 |
2005-03-23 |
Alza Corp |
Composicion osmotica expansible y suspension para revestimiento mejoradas
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
EP1534238A1
(en)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
UY28057A1
(es)
*
|
2002-10-31 |
2003-12-31 |
Alza Corp |
Formulacion y forma de dosificacion que provee mayor biodisponibilidad de los farmacos hidrófobos
|
UY28056A1
(es)
*
|
2002-10-31 |
2003-12-31 |
Alza Corp |
Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
|
US7014636B2
(en)
*
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
US7491234B2
(en)
*
|
2002-12-03 |
2009-02-17 |
Boston Scientific Scimed, Inc. |
Medical devices for delivery of therapeutic agents
|
JP2006510655A
(ja)
*
|
2002-12-11 |
2006-03-30 |
ファイザー・プロダクツ・インク |
高脂肪環境への活性物質の制御放出
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CN1842321B
(zh)
*
|
2003-06-26 |
2012-07-04 |
控制递送系统有限公司 |
生物蚀解性缓释递药系统
|
TWI377958B
(en)
|
2003-06-26 |
2012-12-01 |
Control Delivery Sys Inc |
In-situ gelling drug delivery system
|
EP1635787B1
(en)
*
|
2003-06-26 |
2011-12-14 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
CA2534920A1
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
WO2005020959A2
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
CN1905857A
(zh)
*
|
2003-11-14 |
2007-01-31 |
阿尔扎公司 |
液体剂型的托吡酯的受控释放
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
DK2299275T3
(en)
*
|
2004-07-30 |
2018-05-07 |
Adeza Biomedical Corp |
Classification of oncofetal fetronectin level for pregnancy-related indications
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
CA2596029A1
(en)
*
|
2005-01-27 |
2006-08-03 |
David E. Edgren |
Oral osmotic dosage form having a high flux membrane
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
MX2007015171A
(es)
*
|
2005-06-02 |
2008-04-22 |
Thallion Pharmaceuticals Inc |
Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable.
|
AU2006269944A1
(en)
*
|
2005-07-19 |
2007-01-25 |
Inverseon, Inc. |
Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
EP2359808B1
(en)
*
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
US20080177219A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Joshi Ashok V |
Method for Iontophoretic Fluid Delivery
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
GB0707127D0
(en)
*
|
2007-04-13 |
2007-05-23 |
Zysis Ltd |
Pharmaceutical compositions
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
US8197844B2
(en)
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
US20090312627A1
(en)
*
|
2008-06-16 |
2009-12-17 |
Matott Laura A |
Radio-labeled ingestible capsule
|
CA2638240C
(en)
*
|
2008-08-29 |
2010-02-02 |
Alexander Macgregor |
Method of treating dysglycemia and glucose excursions
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CA3045436A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
SG175137A1
(en)
*
|
2009-04-09 |
2011-11-28 |
Alkermes Pharma Ireland Ltd |
Drug delivery composition
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
EP2432420A4
(en)
*
|
2009-05-18 |
2018-01-10 |
Dose Medical Corporation |
Drug eluting ocular implant
|
AU2010260208B2
(en)
|
2009-06-16 |
2014-11-13 |
Bristol-Myers Squibb Holdings Ireland Unlimited Company |
Dosage forms of apixaban
|
US20130029970A1
(en)
|
2009-07-10 |
2013-01-31 |
Ironwood Pharmaceuticals, Inc |
CB Receptor Agonists
|
US9005661B2
(en)
*
|
2009-09-15 |
2015-04-14 |
Beijing Team Hospital Management Co., Ltd. |
Osmotic pump controlled release tablet and preparation method thereof
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
CN102822163B
(zh)
|
2009-12-23 |
2016-01-20 |
艾恩伍德医药品股份有限公司 |
Crth2调节剂
|
WO2011079050A2
(en)
|
2009-12-23 |
2011-06-30 |
The Smart Pill Corporation |
Method of evaluating constipation using an ingestible capsule
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US20130196960A1
(en)
|
2010-02-09 |
2013-08-01 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Receptor Agonists
|
US20130178453A1
(en)
|
2010-02-09 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Agonists
|
US20130178475A1
(en)
|
2010-03-17 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
AR088020A1
(es)
|
2010-06-30 |
2014-05-07 |
Ironwood Pharmaceuticals Inc |
Compuestos heterociclicos como estimuladores de sgc
|
WO2012009134A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
PT2600930T
(pt)
|
2010-08-05 |
2021-03-22 |
Forsight Vision4 Inc |
Aparelho injetor e método para distribuição de fármacos
|
EP2600812B1
(en)
|
2010-08-05 |
2021-09-22 |
ForSight Vision4, Inc. |
Apparatus to treat an eye
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
BR112013004768A2
(pt)
|
2010-08-30 |
2017-11-21 |
Sinusys Coporation |
dispositivos e métodos para dilatar uma abertura de seio parasanal e para o tratamento de sinusite
|
CN103402515B
(zh)
|
2010-11-09 |
2017-05-17 |
铁木医药有限公司 |
sGC刺激剂
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP2726016B1
(en)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
EP3903733A1
(en)
|
2011-09-16 |
2021-11-03 |
ForSight Vision4, Inc. |
Fluid exchange apparatus
|
CA2861804C
(en)
|
2011-12-27 |
2021-10-26 |
Ironwood Pharmaceuticals, Inc. |
2-benzyl,3(pyrimidin-2-yl)substituted pyrazoles useful as sgc stimulators
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2819740A4
(en)
|
2012-02-29 |
2015-11-25 |
Sinusys Corp |
DEVICES AND METHOD FOR DILATING A PARANASAL SINUS OPENING AND FOR TREATING SINUSITIS
|
WO2013155422A1
(en)
|
2012-04-12 |
2013-10-17 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
US9487508B2
(en)
|
2012-09-19 |
2016-11-08 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
EP3660013B1
(en)
|
2013-03-15 |
2022-01-19 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US9687263B2
(en)
|
2013-05-30 |
2017-06-27 |
SinuSys Corporation |
Devices and methods for inserting a sinus dilator
|
CN113413537A
(zh)
*
|
2013-08-19 |
2021-09-21 |
塔里斯生物医药公司 |
多单元药物递送装置和方法
|
JP7064285B2
(ja)
*
|
2013-12-06 |
2022-05-10 |
デュレクト コーポレーション |
抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
|
CA2933250A1
(en)
|
2013-12-11 |
2015-06-18 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
WO2015184173A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
AU2015289625B2
(en)
|
2014-07-15 |
2019-10-10 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
AU2015301054B2
(en)
|
2014-08-08 |
2020-05-14 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
CA2961489A1
(en)
|
2014-09-17 |
2016-03-24 |
Glen Robert RENNIE |
Sgc stimulators
|
CA2959757A1
(en)
|
2014-09-17 |
2016-03-24 |
Ironwood Pharmaceuticals, Inc. |
Pyrazole derivatives as sgc stimulators
|
US20170298055A1
(en)
|
2014-09-17 |
2017-10-19 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
US11432959B2
(en)
|
2015-11-20 |
2022-09-06 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
ES2837524T3
(es)
|
2016-04-05 |
2021-06-30 |
Forsight Vision4 Inc |
Dispositivos de administración de fármacos oculares implantables
|
CN109937025B
(zh)
|
2016-04-20 |
2022-07-29 |
多斯医学公司 |
生物可吸收眼部药物的递送装置
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
KR102568384B1
(ko)
|
2016-09-02 |
2023-08-22 |
사이클리온 테라퓨틱스, 인크. |
융합된 비시클릭 sGC 자극제
|
CN110267658B
(zh)
|
2016-11-08 |
2024-02-02 |
帝善多制药公司 |
用sGC刺激剂治疗CNS疾病
|
CA3042713A1
(en)
|
2016-11-08 |
2018-05-17 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
IL307966A
(en)
|
2017-01-03 |
2023-12-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|